Sökresultat - "Vehling‐Kaiser, Ursula"

Das Tageshospiz – eine neue Möglichkeit der ambulanten palliativmedizinischen Versorgung

The day hospice—a new option for outpatient palliative care

Kaiser, Ulrich^{Aff1, Aff2, IDs00761024016731_cor1}, Kaiser, Florian, Kaiser, Felix, Fiedler, Moritz, Hoffmann, Ana, Vehling-Kaiser, Ursula

Inhaltliche und strukturelle Erwartungen an ein Tageshospiz: Ergebnisse einer interviewbasierten Studie unter Experten, Patienten und Angehörigen

Content-related and structural expectations of a day hospice: Results of an interview-based study among experts, patients, and relatives

Kaiser, Ulrich^{Aff1, Aff2, IDs0076102401640w_cor1}, Vehling-Kaiser, Ursula, Fiedler, Moritz, Hoffmann, Ana, Chalupper, Romina, Rechenmacher, Michael^{Aff1, Aff4}, Kaiser, Florian

Die nicht-ärztliche onkologische und hämatologische Pflegesprechstunde: Ein zukunftsorientiertes Versorgungsmodell

The non-physician oncology and hematology care consultation: A future-oriented care model

Kaiser, Ulrich^{Aff1, IDs00761024015458_cor1}, Kaiser, Florian, Damnali, Gamze, Vehling-Kaiser, Ursula

COVID-19 – Auswirkung auf das Verhalten von Tumorpatienten

COVID-19—Impact on the behavior of tumor patients

Kaiser, Ulrich^{Aff1, Aff2, IDs0076102401532z_cor1}, Hoffmann, Ana, Fiedler, Moritz, Kück, Fabian, Kaiser, Florian, Vehling-Kaiser, Ursula

Is the use of antibiotic stewardship measures in the context of specialized outpatient palliative care sensible and feasible? An interview-based study

Kaiser, Ulrich^{Aff1, Aff2, IDs1290402401609x_cor1}, Kaiser, Florian, Schmidt, Jörg, Vehling-Kaiser, Ursula^Aff2, Hitzenbichler, Florian^Aff4

The complex intervention day hospice — a quality-assured study on the implementation, realization, and benefits with model character for Germany (IMPULS) using the example of “Day hospice Adiuvantes”

Kaiser, Ulrich^{Aff1, Aff2}, Vehling-Kaiser, Ursula, Hoffmann, Ana, Fiedler, Moritz, Hofbauer, Alexandra, Rechenmacher, Michael^{Aff1, Aff5}, Benning, Anne, Koller, Michael, Kaiser, Florian^{Aff2, IDs12904024013461_cor9}

Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer

Weiss, Lena ^{a, ⁎, 1}, Stintzing, Sebastian ^b, Stahler, Arndt ^b, Benedikt Westphalen, C. ^{a, c}, von Weikersthal, Ludwig Fischer ^d, Decker, Thomas ^e, Kiani, Alexander ^f, Vehling-Kaiser, Ursula ^g, Al-Batran, Salah-Edin ^h, Heintges, Tobias ⁱ, Lerchenmüller, Christian A. ^j, Kahl, Christoph ^{k, l, m}, Seipelt, Gernot ^{m, n}, Kullmann, Frank ^{n, o}, Heinrich, Kathrin ^a, Holch, Julian Walter ^a, Alig, Annabel ^b, Jung, Andreas ^{o, p}, Modest, Dominik Paul ^b, Heinemann, Volker ^{a, c}

Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?

Weiss, Lena^{Aff1, Aff2}, Heinemann, Volker^{Aff1, Aff2, Aff3}, Fischer, Laura E.^{Aff1, Aff2}, Gieseler, Frank, Hoehler, Thomas, Mayerle, Julia^{Aff2, Aff6}, Quietzsch, Detlef, Reinacher-Schick, Anke, Schenk, Michael, Seipelt, Gernot, Siveke, Jens T.^{Aff11, Aff15}, Stahl, Michael, Vehling-Kaiser, Ursula, Waldschmidt, Dirk T., Dorman, Klara^{Aff1, Aff2, Aff3}, Zhang, Danmei^{Aff1, Aff2, Aff3}, Westphalen, C. Benedikt^{Aff1, Aff2}, von Bergwelt-Baildon, Michael^{Aff1, Aff2, Aff3}, Boeck, Stefan^{Aff1, Aff2, Aff3}, Haas, Michael^{Aff1, Aff2, IDs12094023033231_cor20}

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

Al-Sawaf, Othman^{Aff1, Aff2, Aff3, IDs41591023027229_cor1}, Ligtvoet, Rudy, Robrecht, Sandra, Stumpf, Janina, Fink, Anna-Maria, Tausch, Eugen, Schneider, Christof, Boettcher, Sebastian, Mikusko, Martin, Ritgen, Matthias, Schetelig, Johannes, von Tresckow, Julia, Vehling-Kaiser, Ursula, Gaska, Tobias, Wendtner, Clemens Martin, Chapuy, Bjoern^{Aff13, Aff14}, Fischer, Kirsten, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Staber, Philipp, Niemann, Carsten, Hallek, Michael, Eichhorst, Barbara^{Aff1, IDs41591023027229_cor23}

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

Ababei, Juliana, Alt, Jürgen, Ammon, Andreas, Anhuf, Jürgen, Azeh, Ivo, Bauer, Stefan, Behringer, Dirk, Berger, Winfried, Bernhardt, Christiane, Bertram, Mathias, Boesche, Michael, Bohnet, Sabine, Bruch, Harald-Robert, Brückl, Wolfgang, Burkhard-Meier, Ulrike, Christopoulos, Petros, Däßler, Klaus-Ulrich, de Wit, Maike, Dechow, Tobias, Depenbusch, Reinhard, Dietze, Lutz, Dommach, Markus, Dörfel, Steffen, Eberhardt, Wilfried, Elender, Corinna, Elsel, Wolfgang, Emde, Till-Oliver, Faehling, Martin, Fietz, Thomas, Fischer, Jürgen R., Flieger, Dimitri, Freidt, Anke, Freier, Werner, Frenzel, Christian, Fuchs, Florian, Fuchs, Roswitha, Gaska, Tobias, Gleiber, Wolfgang, Grah, Christian, Griesinger, Frank, Grohé, Christian, Groschek, Matthias, Güldenzoph, Björn, Günther, Andreas, Haas, Siegfried, Hackenthal, Matthias, Hagen, Volker, Hahn, Lars, Hannig Carla, Verena, Hansen, Richard, Harich, Hanns-Detlev, Heilmann, Monika, Heinrich, Kathrin, Hering-Schubert, Christiane, Heßling, Jörg, Hoffknecht, Petra, Hortig, Patricia, Hübner, Gerdt, Hummel, Horst-Dieter, Hutzschenreuter, Ulrich, Illmer, Thomas, Innig, Georg, Jaeschke, Bastian, Junghanß, Christian, Kaiser, Ulrich, Kamal, Haytham, Kambartel, Kato, Kern, Jens, Kimmich, Martin, Kingreen, Dorothea, Kirchen, Heinz, Klausmann, Martine, Klein, Ortwin, Kokowski, Konrad, Körber, Wolfgang, Kortsik, Cornelius, Koschel, Dirk, Krämer, Benoit, Krammer-Steiner, Beate, Laack, Eckart, Lamberti, Christof, Leistner, Rumo David, Losem, Christoph, Lück, Andreas, Maintz, Christoph, Martin, Kerstin, Medgenberg, Dirk, Metzenmacher, Martin, Meyer zum Büschenfelde, Christian, Meyn, Philipp, Moorahrend, Enno, Müller, Annette, Müller, Lothar, Neise, Michael, Nückel, Holger, Nusch, Arnd, Overbeck, Tobias, Pelz, Henning, Petersen, Volker, Peuser, Bettina, Plath, Margarete, Randerath, Winfried J., Rauh, Jacqueline, Reck, Martin, Reichert, Dietmar, Reinmuth, Niels, Reiser, Marcel, Repp, Roland, Reschke, Daniel, Rittmeyer, Achim, Rodemer, Yolanda, Sackmann, Sandra, Sadjadian, Parvis, Sandner, Reiner, Sauer, Annette, Schäfer, Harald, Schaudt, Christoph, Schlag, Rudolf, Schmidt, Burkhard, Schmitz, Stephan, Schröder, Jan, Schroeder, Michael, Schulze, Mathias, Schumann, Christian, Schütte, Wolfgang, Schwaiblmair, Martin, Schwindt Peter, Florian, Sebastian, Martin, Seese, Bernd, Seipelt, Gernot, Sorgenfrei, Thomas, Steiff, Johannes, Steiniger, Heike, Trarbach, Tanja, Tufman, Amanda, Uhlig, Jens, Vehling-Kaiser, Ursula, von der Heyde, Eyck, von Verschuer, Ulla, Waller, Cornelius, Wehler, Thomas, Weißenborn, Georg, Weißinger, Florian, Wermke, Martin, Wesseler, Claas, Wiegand, Jörg, Wilhelm, Stefan, Wilke, Jochen, Zahn, Mark-Oliver, Zaiss, Matthias, Zeth, Matthias, Eberhardt, Wilfried E.E., Brueckl, Wolfgang M., Jänicke, Martina, Fleitz, Annette, Zacharias, Stefan, Hipper, Annette, Groth, Annika, Weichert, Wilko, Thomas, Michael

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

Ohnmacht, Alexander J.^{Aff1, Aff2}, Stahler, Arndt, Stintzing, Sebastian^{Aff3, Aff4}, Modest, Dominik P., Holch, Julian W.^{Aff4, Aff5}, Westphalen, C. Benedikt, Hölzel, Linus, Schübel, Marisa K.^{Aff1, Aff2}, Galhoz, Ana^{Aff1, Aff2}, Farnoud, Ali, Ud-Dean, Minhaz, Vehling-Kaiser, Ursula, Decker, Thomas, Moehler, Markus, Heinig, Matthias, Heinemann, Volker^{Aff5, IDs41467023410114_cor16}, Menden, Michael P.^{Aff1, Aff2, Aff9, IDs41467023410114_cor17}

SAPV-Patienten in der COVID-19-Krise: Eine interviewbasierte Studie über Erfahrungen von Palliativpatienten

SAPV patients in the COVID-19 crisis: An interview-based study of palliative care patients’ experiences

Kaiser, Ulrich^{Aff1, IDs00761022011896_cor1}, Vehling-Kaiser, Ursula, Kalteis, Martin, Hoffmann, Ana, Schmidt, Jörg, Kaiser, Florian^{Aff2, Aff6}

The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia

Langerbeins, Petra ^*, Zhang, Can, Robrecht, Sandra, Cramer, Paula, Fürstenau, Moritz, Al-Sawaf, Othman, von Tresckow, Julia, Fink, Anna-Maria, Kreuzer, Karl-Anton, Vehling-Kaiser, Ursula, Tausch, Eugen, Müller, Lothar, Eckart, Michael Josef, Schlag, Rudolf, Freier, Werner, Gaska, Tobias, Balser, Christina, Reiser, Marcel, Stauch, Martina, Wendtner, Clemens-Martin, Fischer, Kirsten, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael

Oral and Subcutaneous Anticancer Therapy Training Course for Non-physician Healthcare Professionals: a Survey Evaluating the Relevance of its Content and its Implications in the Practice of Cancer Care

Shumilov, Evgenii, Vehling-Kaiser, Ursula, Damnali, Gamze^{Aff2, Aff3}, Schulz, Xenia, Kaiser, Ulrich, Bacher, Ulrike^{Aff6, Aff7}, Kaiser, Florian^{Aff1, IDs13187020017942_cor7}

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Befragung von Hausärzt*innen zur Versorgung von Patienten unter oralen Tyrosinkinaseinhibitoren

Kaiser, Florian, Schulz, Xenia, Hoffmann, Ana, Kaiser, Felix, Vehling-Kaiser, Ursula, Kaiser, Ulrich

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.